| Sr. No. |
Authors |
Title |
Published in /
Presented at |
Type |
PDF |
Links |
|
|
|
|
|
|
|
| 1. Supralimus® |
|
|
|
|
|
|
|
| 1 |
A. Abhyankar, S. Dani, D. Desai et al. |
Evaluation of safety, efficacy and procedural outcomes of extra long sirolimus eluting stent with novel polymeric technology for treatment of long De Novo coronary lesions |
Catherterization and Cardiovascular Intervention 2006 |
Abstract |
 |
|
|
| 2 |
Siqueira D, Costa RA, Costa JR et al |
Supralimus biodegradable Sirolimus-Eluting stent technology in diabetic patients undergoing percutaneous coronary intervention (PCI):
Preliminary findings from the Prospective, international, multicenter E-SERIES Registry |
The American Journal of Cardiology (October12-17,2008):167i |
Abstract |
|
|
|
| 3 |
Costa RA, Abizaid A, Abizaid AS, et al |
Six-month clinical outcomes of sirolimus-eluting stents with a biodegradable polymer for the treatment of unselected patients with Complex coronary lesions-Preliminary results from the
prospective, multicenter E-SERIES Registry |
Journal of The American College of Cardiology (March-2009);2501-537:A15 |
Abstract |
|
 |
|
| 4 |
Ricardo Costa, Alexandre Abizaid, Andrea Abizaid et al |
Complex patients
with coronary artery disease treated with the novel
supralimus sirolimus-eluting stents. Preliminary
results of the prospective, multicenter, non-randomized
E-SERIES Trial |
EuroIntervention
2009;5:E44 (Abstract of EuroPCR 2009) |
Abstract |
|
|
|
| 5 |
Costa JR, Abizaid A, Machado B, et al. |
Supralimus Biodegradable-polymer sirolimus-eluting stent technology in patients with Acute Coronary Syndrom: Two-year results of the prospective, multicenter E-SERIES Registry |
Journal of The American College of Cardiology (March-2010); 55(10A) |
Abstract |
|
|
|
| 6 |
Sameer Dani, Neville Kukreja,Prakashvir Parikh et al |
Biodegradable-polymer-based, sirolimus-eluting Supralimus® stent: 6-month angiographic and 30-month clinical follow-up results from the Series I prospective study |
EuroIntervention |
Article |
|
|
|
| 7 |
Ricardo Costa; Alexandre Abizaid; Andrea Abizaid et al. |
Six-Month Clinical Outcomes of Sirolimus-Eluting Stents with a Biodegradable Polymer for the Treatment of Unselected Patients with Complex Coronary Lesions: Preliminary Results from the Prospective, Multicenter E-Series Registry |
EuroPCR-2009 |
Presentation |
|
|
|
|
|
|
|
|
|
| 2. Supralimus-Core® |
|
|
|
|
|
|
|
| 1 |
Ashok Seth |
Safety and Efficacy of Sirolimus Eluting SUPRALIMUS-CORE® Stent at Max Heart Institute In the Treatment of De Novo Native Coronary Artery Lesions - MAXIMUS Study |
TCT-2007 |
Presentation |
|
|
|
|
|
|
|
|
|
| 2 |
Ashok Seth |
Safety and Efficacy of Sirolimus Eluting SUPRALIMUS-CORE® Stent at Max Heart Institute In the Treatment of De Novo Native Coronary Artery Lesions - MAXIMUS Study |
EuroPCR-2007 |
Presentation |
|
|
|
|
|
|
|
|
|
| 3. Infinnium® |
|
|
|
|
|
|
|
| 1 |
P. Vranckx; P.W. Serruys; D. S. Gambhir et al. |
Biodegradable-polymer-based, paclitaxel-eluting Infinnium Stent: 9-month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study |
EuroIntervention |
Article |
|
|
|
|
|
|
|
|
|
| 2 |
Aytekin Vedat, Gormez Selcuk, Erdim Refik et al. |
Treatment of patients with coronary artery disease with biodegradable polymer based paclitaxel-eluting Infinnium® coronary stent system: Results of 1-Year Clinical Follow-up. A Single Centre Experience |
Indian Heart Journal |
Article |
|
|
|
|
|
|
|
|
|
| 3 |
Mohammad A Ostovan; Reza Mollazadeh; Javad Kojuri et al. |
Experience with Paclitaxel-Eluting Infinnium® Coronary Stents |
Asian Cardiovascular & Thoracic Annals |
Article |
--- |
|
|
|
|
|
|
|
|
| 4 |
Periklis A. Davlouros, George Nikokiris, Vasileios Karantalis, et al. |
"Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: An optical coherence tomography study" |
International Journal of Cardiology |
Article |
--- |
|
|
| 5 |
Periklis A. Davlouros, Eleni Mavronasiou, Ioanna Xanthopoulou, et al. |
"An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9" |
International Journal of Cardiology |
Article |
--- |
|
|
|
|
|
|
|
|
| 4 |
Supralimus® and Supralimus-Core® |
|
|
|
|
|
|
|
| 1 |
Ashok Seth |
The SAHAJANAND (SMT) Bioabsorbable Polymer based SES Stent Trial Program (SERIES and MAXIMUS Results) |
TCT-2008 |
Presentation |
|
|
|
|
|
|
|
|
|
| 5 |
Supralimus®, Supralimus-Core® and Infinnium® |
|
|
|
|
|
|
|
| 1 |
Layth A. Mimish |
Bioabsorbable-polymer-DES Saudi Registry with 3 year followup |
EuroPCR 2011 |
Presentation |
|
|
|
|
|
|
|
|
|
| 6 |
Supralimus®, Infinnium® and Matrix® |
|
|
|
|
|
|
|
| 1 |
Pedro A. Lemos; Bruno Moulin; Marco A. Perin et al |
Biodegradable-polymer Infinnium Paclitaxel-eluting and Supralimus Sirolimus-eluting stents reduce repeat intervention in complex cases: Findings from the 3-arm PAINT Randomized Controlled Trial |
Poster presentation in e-poster no: 4139 ESC Congress-2008 |
Post Presentation |
--- |
|
|
| 2 |
Pedro A. Lemos, Bruno Moulin, Marco A. Perin et al. |
Rationale and Design for the PAINT Randomized Trial |
Arquivos Brasileiros de Cardiologia |
Article |
--- |
|
|
| 3 |
Pedro A. Lemos, Bruno Moulin, Marco A. Perin et al. |
Randomized evaluation of two Drug-Eluting Stents with identical metallic platform and biodegradable polymer but different agents (Paclitaxel or Sirolimus) compared against Bare Stents: 1-Year results of the PAINT Trail |
Catheterization and Cardiovascular Interventions |
Article |
--- |
|
|
| 4 |
Pedro A. Lemos |
Clinical Trials with SMT Supralimus Sirolimus-Eluting Stent (SERIES I and PAINT) |
TCT-2007 |
Presentation |
|
|
|
| 5 |
Pedro A. Lemos |
PercutAneous INTervention with biodegradable-polymer based paclitaxel-eluting, sirolimus-eluting, or bare stents for the treatment of de novo coronary lesions - PAINT Trial |
EuroPCR-2008 (Late breaking trials) |
Presentation |
|
|
|
| 6 |
Pedro A. Lemos; Bruno Moulin, Marco A. Perin et al |
Biodegradable-polymer Infinnium paclitaxel-eluting and Supralimus sirolimus-eluting stents reduce repeat intervention in complex cases - PAINT Complex Trial |
ESC Congress-2008 |
Presentation |
|
|
|
| 7 |
Pedro A. Lemos |
Late Results from the PAINT Trial |
TCT-2010 |
Presentation |
|
|
|
|
|
|
|
|
|
